Sarepta Therapeutics
SRPT
#1448
Rank
โ‚น1.020 T
Marketcap
โ‚น10,682
Share price
-2.66%
Change (1 day)
25.14%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น119.91 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total debt is โ‚น119.91 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sarepta Therapeutics - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น116.28 B-13.12%
2022-12-31โ‚น133.83 B55.89%
2021-12-31โ‚น85.85 B9.42%
2020-12-31โ‚น78.46 B50.8%
2019-12-31โ‚น52.02 B76.94%
2018-12-31โ‚น29.40 B6.84%
2017-12-31โ‚น27.52 B2407.85%
2016-12-31โ‚น1.09 B-29.42%
2015-12-31โ‚น1.55 B287.71%
2014-12-31โ‚น0.40 B289.19%
2013-12-31โ‚น0.10 B7.12%
2012-12-31โ‚น96.2 M-1.27%
2011-12-31โ‚น97.44 M13.08%
2010-12-31โ‚น86.16 M-7.19%
2009-12-31โ‚น92.84 M-25.42%
2008-12-31โ‚น0.12 B48.1%
2007-12-31โ‚น84.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น1.994 T 1,563.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น20.01 B-83.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.65 B-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น69.42 B-42.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น111.70 B-6.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น34.33 B-71.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น85.79 B-28.46%๐Ÿ‡บ๐Ÿ‡ธ USA